NCT06990100View on ClinicalTrials.gov

Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 12, 2025

Conditions

ACL Rupture

Interventions

DEVICE

ACL surgery

ligamentoplasty surgery - ACL reconstruction surgery

Trial Locations (1)

31036

Clinique MEDIPOLE GARONNE, Toulouse

All Listed Sponsors

lead

SACIMEX

INDUSTRY

NCT06990100 - Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study | Biotech Hunter | Biotech Hunter